Inovio Pharmaceuticals In... (INO)

AI Score

Unlock

1.58

0.00 (0.00%)

At close: Apr 11, 2025, 9:35 AM

Inovio Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	65.81B	14.31M	46.33M	71.14M	250.73M	22.2M	23.69M	23.79M	19.14M
Short-Term Investments	28.3B	130.98M	206.67M	330.17M	160.91M	67.34M	57.54M	103.64M	85.63M
Long-Term Investments	1.61B	2.78M	2.01M	3.91M	4.89M	6.32M	9.41M	11.39M	19.83M
Other Long-Term Assets	1.98B	605.32K	684.04K	1.43M	25.96M	2.67M	2.67M	2.64M	2.11M
Receivables	1.2M	2.41M	11.74M	8.03M	19.06M	2.03M	4.05M	6.49M	16.57M
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	2.52B	20.43K	30.38M	261.19K	n/a	n/a	n/a	n/a	n/a
Total Current Assets	97.83B	153.11M	315.24M	448.44M	471.17M	94.2M	87.81M	138.36M	124.6M
Property-Plant & Equipment	11.77B	14.45M	17.96M	29.02M	24.09M	26.56M	15.95M	18.32M	9.03M
Goodwill & Intangibles	n/a	n/a	12.64M	13.14M	13.66M	14.21M	15.27M	16.52M	18.14M
Total Long-Term Assets	15.37B	17.84M	33.29M	47.5M	68.6M	49.75M	43.3M	48.88M	49.11M
Total Assets	113.2B	170.95M	348.53M	495.94M	539.77M	143.95M	131.11M	187.24M	173.71M
Account Payables	6.44M	4.65M	21.08M	27.97M	1.47M	7.65M	11.02M	8.49M	6.99M
Deferred Revenue	n/a	n/a	n/a	21.63K	46.63K	124.13K	257.15K	1.35M	15.17M
Short-Term Debt	2.5B	16.77M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	32.82B	9.95M	15.14M	20.71M	20.66M	15.74M	14.73M	9.24M	8.15M
Total Current Liabilities	35.33B	42.57M	96.87M	65.74M	41.71M	31.99M	35.3M	35.41M	43.82M
Long-Term Debt	9.37B	n/a	16.61M	14.96M	18.66M	77.02M	n/a	n/a	n/a
Other Long-Term Liabilities	-9.37M	n/a	n/a	14.83K	95.16K	8.99M	8.61M	9.1M	5.93M
Total Long-Term Liabilities	9.37B	11.03M	29.3M	30.53M	36.93M	106.56M	8.78M	9.35M	6.51M
Total Liabilities	44.69B	53.6M	126.17M	96.27M	78.63M	138.55M	44.08M	44.75M	50.33M
Total Debt	11.87B	30.21M	32.07M	33.02M	39.05M	99.51M	n/a	n/a	n/a
Common Stock	36.1K	22.79K	21.09K	217.38K	186.85K	101.36K	97.23K	90.36K	74.06K
Retained Earnings	-1,730.2B	-1.62B	-1.49B	-1.21B	-906.2M	-739.79M	-620.43M	-523.36M	-434.84M
Comprehensive Income	-675.67M	-662.6K	-698.74K	-282.24K	-256.15K	472.61K	-528.87K	-117K	1.33M
Shareholders Equity	68.5B	117.35M	222.36M	399.67M	461.14M	3.44M	86.94M	142.39M	123.28M
Total Investments	29.91B	133.76M	208.68M	334.08M	165.81M	73.65M	66.94M	115.03M	105.46M